Clin2
NCT07869537Possibly a fitRecruiting

Simplified tranexamic acid dosing for major bleeding after injury

Trauma CoagulopathyHemorrhage

Treatments studied

Part of Blood & lymphatic, Heart & circulation, Injuries & trauma clinical trials.

This trial tests a simpler way to give a drug called tranexamic acid to trauma patients with heavy bleeding. The drug helps blood clot and may reduce bleeding, but it is important to check if the simplified approach is as safe as the standard one.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
60 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You were injured within the last 3 hours.
  • You are bleeding heavily (for example, very low blood pressure or a very fast heartbeat).
  • You are not pregnant.
  • You do not have a history of blood clots, stroke, heart attack, or seizures.
  • You are not allergic to tranexamic acid.
  • You have not received tranexamic acid before arriving at the hospital.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06736860Recruiting· Phase 4
Tranexamic acid for trauma bleeding with blood clot monitoring

This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.

Guangzhou, Guangdong
NCT04387305Not yet recruiting· Phase 3
Tranexamic acid for bleeding after injury in children

This trial tests whether giving tranexamic acid (TXA), a medicine that helps blood clot, reduces death and disability in children who have bleeding after a severe injury. It is given within 3 hours of the injury, and could help children with head or torso trauma who are at risk of serious bleeding.

NCT06070350Recruiting· Phase 3
Massive transfusion for life-threatening bleeding in children

This study tests whether adding the drug tranexamic acid (TXA) to a massive blood transfusion helps control life-threatening bleeding in children who are severely injured. It compares two groups: one gets TXA and the other gets a placebo (a dummy drug with no active ingredient).

Tucson, Arizona
NCT05047133Recruiting· Phase 2/Phase 3
Early TXA treatment for adult hip fracture surgery

This study tests whether giving a blood-clot-reducing medicine (TXA) early after an adult hip fracture helps reduce bleeding and related problems around surgery. It may help some patients getting operative fixation by improving safety during recovery.

Grand Blanc, Michigan
NCT05836831Recruiting· Phase 4
Tranexamic acid for sudden brain bleeding after stroke

This trial studies whether tranexamic acid (a medicine that helps blood clot) can improve outcomes after a spontaneous (not caused by injury) brain bleed. It is designed for adults who arrive soon after stroke symptoms start and meet several safety and timing requirements.

Guntur, Andhra Pradesh
NCT06657924Recruiting· Phase 2
TXA to Prevent Bleeding in Colorectal Surgery

This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.

Cleveland, Ohio

Hear when a new Trauma Coagulopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.